Jong Cheol Jeong

Bias reduction for semi-competing risks frailty model with rare events: application to a chronic kidney disease cohort study in South Korea.

Jayoun Kim, Kook-Hwan Oh, Donghwan Lee, 2023, Lifetime data analysis.

Executive Summary of the Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment

S. H. Kim, K. Oh, Y. Hwang, 2021, Kidney research and clinical practice.

Circulating osteoprotegerin levels and cardiovascular outcomes in patients with pre-dialysis chronic kidney disease: results from the KNOW-CKD study

H. Choi, E. Bae, S. Kim, 2024, Scientific reports.

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

N. Perico, M. Jardine, V. Perkovic, 2023, The Lancet.